Clinical Trial

A Study of ENX-104 in Healthy Participants

Name: A Study of ENX-104 in Healthy Participants — clinical trial record (NCT07472361)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Completed Phase 1

View on ClinicalTrials.gov →

Summary

The study is designed to evaluate the relative bioavailability, safety, and tolerability of a single dose of ENX-104 administered orally as a solution fasted, a tablet fasted, or a tablet with a high fat meal in healthy participants

Protocol Amendment History 1 change

critical Trial completed 2026-04-23

Trial Details

NCT Number	NCT07472361
Lead Sponsor	Engrail Therapeutics INC
Conditions	Healthy Volunteers
Enrollment	12 participants
Start Date	2026-02-25
Primary Completion	2026-03-19 (estimated)
Study Completion	2026-03-19 (estimated)
Updated on ClinicalTrials.gov	2026-04-22